BioNTech SE (BNTX) Total Liabilities (2018 - 2022)

BioNTech SE's Total Liabilities history spans 4 years, with the latest figure at $4.5 billion for Q4 2021.

  • For Q4 2021, Total Liabilities rose 298.98% year-over-year to $4.5 billion; the TTM value through Dec 2021 reached $4.5 billion, up 298.98%, while the annual FY2021 figure was $4.5 billion, 298.98% up from the prior year.
  • Total Liabilities for Q4 2021 was $4.5 billion at BioNTech SE, up from $1.1 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $4.5 billion in Q4 2021 and bottomed at $336.7 million in Q4 2019.
  • The 4-year median for Total Liabilities is $784.7 million (2020), against an average of $1.6 billion.
  • The largest annual shift saw Total Liabilities fell 23.58% in 2019 before it soared 298.98% in 2021.
  • A 4-year view of Total Liabilities shows it stood at $440.6 million in 2018, then dropped by 23.58% to $336.7 million in 2019, then soared by 235.31% to $1.1 billion in 2020, then skyrocketed by 298.98% to $4.5 billion in 2021.
  • Per Business Quant, the three most recent readings for BNTX's Total Liabilities are $4.5 billion (Q4 2021), $1.1 billion (Q4 2020), and $336.7 million (Q4 2019).